NGL Fine-Chem informs about outcome of board meeting

06 Mar 2025 Evaluate

NGL Fine-Chem has informed that the fourth Meeting of the Board of Directors of the company for the Financial Year 2024-2025 held today on Friday, 7th February, 2025, where in Board has approved the Unaudited Standalone & Consolidated Financial Results for the quarter and nine months ended 31st December, 2024 pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 along with Limited Review Report issued by the Statutory Auditors of the Company. The aforesaid results are also being disseminated on Company's website at www.nglfinechem.com. The meeting of the Board of Directors commenced at 6.00 pm and concluded at 7.00 pm.

The above information is a part of company’s filings submitted to BSE.

NGL Fine-Chem Share Price

1114.40 -20.70 (-1.82%)
28-Mar-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1735.45
Dr. Reddys Lab 1144.05
Cipla 1441.70
Lupin 2026.50
Zydus Lifesciences 885.70
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...